ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

PNTG vs TDOC // ALTMAN Z-SCORE & DEBT/EQUITY

The Pennant Group Inc. (NASDAQ) VS. Teladoc Health Inc. (NYSE) • 15-METRIC TALLY: PNTG 5 — TDOC 4
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: PNTG
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PNTG VS. TDOC) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC PNTG TDOC SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 11.00% -17.00% +28.00 PNTG /roic <GO>
EV/EBITDA & P/E Valuation 23.9x — — TIE /valuation <GO>
Free Cash Flow Yield 2.44% 18.00% -15.56 TDOC /fcf-yield <GO>
Operating Margin 5.50% -10.40% +15.90 PNTG /operating-margins <GO>
Net Profit Margin 3.10% -7.90% +11.00 PNTG /net-margins <GO>
Revenue Growth (YoY) 36.30% -1.50% +37.80 PNTG /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity ACTIVE 2.81 0.45 +2.36 PNTG /balance-sheet <GO>
Piotroski F-Score Quality 7/9 7/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 52.7 74.1 -21.40 TDOC /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 1.08 — TIE /macro-sensitivity <GO>
Forward P/E Multiple 42.2x 32.0x +10.20 TDOC /forward-pe <GO>
Enterprise Scale & Market Cap $1.46B $1.55B -$96.2M TDOC /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR PNTG REV TDOC REV PNTG GROSS % TDOC GROSS % PNTG FCF TDOC FCF
FY 2025 $947.7M $2.53B — — $36.3M $285.5M
FY 2024 $695.2M $2.57B — — $30.3M $282.9M
FY 2023 $544.9M $2.60B — — $33.1M $232.9M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PNTG // BETA —
TDOC // BETA 1.08